Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Vanguard›VHT

VHT

Vanguard Health Care ETF

Passive ETF Equity

The VHT Exchange Traded Fund (ETF) is provided by Vanguard. It is built to track an index: MSCI US IMI Health Care 25/50 Index. The VHT ETF provides physical exposure, so by buying it you actually own parts of all the 419 underlying holdings. This share class generates a stream of income by distributing dividends.

$307.15

-$4.2 (-1.34%) yesterday

1:30 PM 07/30/26 Closed

1D price range

$303.91$307.42

52W price range

$239.11$313.05

YTD Perf.

+7.46%

YTD Flows

Annualized volatility

Fund AuM

€15.95B

Share class AuM

€15.95B

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US92204A5048

TER

0.09%

Inception date

1/26/2004

Issuer

Vanguard

Benchmark

MSCI US IMI Health Care 25/50 Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
FHLC Fidelity MSCI Health Care Index ETF	+3.79%
IYH iShares U.S. Healthcare ETF	+1.16%
XUHC Xtrackers MSCI USA Health Care UCITS ETF	+4.14%
453640 SAMSUNG Kodex S&P500 Health Care ETF	+1.77%
XLV State Street Health Care Select Sector SPDR ETF	+1.24%
IUHC iShares S&P 500 Health Care Sector UCITS ETF	+1.23%
SXLV State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF	+1.23%
ZXLV BMO SPDR Health Care Select Sector Index ETF	+0.72%
XLVI State Street Health Care Select Sector SPDR Premium Income Fund	+0.97%
UMDV iShares US Medical Devices UCITS ETF	+6.28%
FTXH First Trust Nasdaq Pharmaceuticals ETF	+2.90%
XDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF	+4.84%
IHE iShares U.S. Pharmaceuticals ETF	+0.47%
IHI iShares U.S. Medical Devices ETF	+6.62%
BMED iShares Health Innovation Active ETF	+1.45%

API

PerformanceDec 31, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

97.39%

Consumer Non-Cyclicals

1.94%

Unavailable

0.54%

Other

0.11%

Latest VHT news

How Global Demographics Support Healthcare ETFs

Smart Investing · April 19, 2023

FAQ about VHT

VHT is a Passive ETF. This ETF provides exposure to US Health Care Equities.

VHT tracks the MSCI US IMI Health Care 25/50 GTR Index - USD, through a full replication replication method.

VHT carries a total expense ratio (TER) of 0.09%, indicating the annual cost for holding the fund.

VHT was introduced to the market on January 26, 2004. It trades on United States

Vanguard Health Care ETF, VHT, is provided by Vanguard. Learn more about Vanguard here.

VHT oversees €15.95B in assets as of July 30, 2026.

VHT follows a distributing dividend policy, meaning it pays out income to investors. As of July 30, 2026, its 12-month trailing yield was 1.54%.

As of June 30, 2026, VHT has significant geographic allocations in USA and Ireland.

As of June 30, 2026, VHT focuses largely on Healthcare and Consumer Non-Cyclicals.

As of June 30, 2026, VHT holds 419 positions in its portfolio, with 61.42% of assets concentrated in its top 15 holdings.

As of June 30, 2026, VHT top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

The base currency of VHT is USD.

Top 10 holdings

Data as of 06/30/26

Eli Lilly & Co.

14.16%

Johnson & Johnson

8.87%

AbbVie, Inc.

6.54%

UnitedHealth Group, Inc.

5.55%

Merck & Co., Inc.

4.67%

Amgen, Inc.

2.87%

Thermo Fisher Scientific, Inc.

2.74%

Abbott Laboratories

2.32%

Gilead Sciences, Inc.

2.31%

Intuitive Surgical, Inc.

2.08%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Vanguard Health Care ETF

FAQ about VHT

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US